BioCentury
ARTICLE | Clinical News

DC Bead regulatory update

August 12, 2013 7:00 AM UTC

Eisai disclosed in its 1Q13 earnings that DC Bead was approved in Japan as a device for transcatheter arterial embolization (TAE) therapy in patients with hepatocellular carcinoma (HCC). DC Bead is ap...